Viewing Study NCT07453732


Ignite Creation Date: 2026-03-26 @ 3:16 PM
Ignite Modification Date: 2026-03-30 @ 12:15 AM
Study NCT ID: NCT07453732
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-03-24
First Post: 2026-02-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Banana Leaves as a Wound Dressing for Partial Thickness Second Degree Burns in Adult Patients.
Sponsor: University of Colorado, Denver
Organization:

Study Overview

Official Title: Pilot Study of Banana Leaves as a Primary Wound Dressing for Partial Thickness Burn Wounds
Status: NOT_YET_RECRUITING
Status Verified Date: 2026-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study plans to look at the benefits of banana leaves as a primary burn wound dressing. Study patients will be compared to historical patients
Detailed Description: Historically, banana leaves have been used as a burn wound dressing in developing countries. Current literature on banana leaf dressings is limited to predominantly pediatric patients and surgical wounds (i.e. skin graft donor sites). The comparison dressing is often other non-standard burn dressings (e.g. boiled potato peel bandage) and these studies are almost exclusively performed in tropical locations where banana plants grow naturally (Africa and Asia). To date, no study on the effectiveness of banana leaf dressings has been done in the United States, nor has there been a focus on their effectiveness in second degree partial thickness burns. Our pilot study aims to establish the feasibility of using banana leaf dressings for second degree partial thickness burn wounds in adult patients, in a geographic location that does not support natural banana agriculture.

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: